PlushCare logo

PlushCare Review

Best for: virtual primary care that can also prescribe GLP-1s

Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent). PlushCare offers virtual visits with US board-certified physicians at $30 insured / $129 self-pay per appointment, with GLP-1 prescribing as a clinician-discretionary option within the broader primary-care relationship.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.0
★★★3.5
BrandWegovyOzempicZepboundMounjaroSaxendaAll 50 StatesVirtual Primary Care
$149/mo

What the monthly price covers

Medication

Billed separately

Provider visits

Billed separately

Shipping

Not disclosed

Lab work

Billed separately

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

PlushCare is a solid telehealth option with balanced features and pricing.

Score: 7/10Best for: virtual primary care that can also prescribe GLP-1sFrom: $149/mo
PlushCare logo
3.5 / 5
Our editorial rating
Visit PlushCare

from $149/mo · no insurance needed

PlushCare at a glance

Type
GLP-1 telehealth provider
Medications
Wegovy, Ozempic, Zepbound, Mounjaro
Starting price
$149/mo (Range up to $299/mo)
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored PlushCare

Each dimension is scored algorithmically from PlushCare’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

7.5/10

At $149/mo, PlushCare runs about 12% below the $170 median for GLP-1 providers.

Effectiveness25%

7.5/10

PlushCare offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.6/10

Online intake and platform experience; 8 platform features disclosed.

Trust & Safety15%

6.7/10

Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).

Accessibility10%

7.7/10

PlushCare treats patients in all 50 states.

Support10%

5.3/10

PlushCare provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this PlushCare review

Last checked 2026-06-03
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications PlushCare offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

StartingCompounded
$149/mo
semaglutide

Range up to $299/mo

StartingCompounded
$399/mo
tirzepatide

Range up to $599/mo

Ready to get started?

Plans and promotions change often — check PlushCare's current pricing and active discounts before you decide.

See PlushCare pricing →

What we like

  • Available in all 50 states
  • Appointments with US board-certified physicians, not nurse practitioners only
  • Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
  • Owned by Transcarent, a venture-backed health platform with a named corporate parent

Watch-outs

  • Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
  • GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
  • BBB complaints center on the membership cancellation process

PlushCare is a primary-care doctor's office online — not a GLP-1 weight-loss program

The first thing to understand about PlushCare is that it isn't built around weight loss at all. It's a virtual primary-care service: you book a video appointment with a US board-certified physician, and that doctor can handle whatever you bring to the visit — a sinus infection, a refill, blood-pressure management, or a conversation about a GLP-1. Prescribing a weight-loss medication is one thing a PlushCare doctor *can* do, at their discretion, but it is not the product you're signing up for. If you want a purpose-built, here's-your-shot-in-the-mail GLP-1 program, this is the wrong door. If you want a real doctor who can manage your overall health and *might* prescribe a GLP-1 as part of that, PlushCare makes more sense.

How the money actually works: a visit fee plus a membership, and the medicine is separate

PlushCare does not bundle anything. You pay per appointment — a low copay-style rate if you use insurance, or a higher self-pay rate if you don't — and on top of that there's a recurring monthly membership fee in the low-twenties range. Neither of those covers your actual medication or any lab work. PlushCare's own checkout language spells it out: medication and lab costs are not included. That's a fundamentally different model from the all-in compounded programs we rank, where one monthly figure covers the drug, the clinician, and shipping.

Because the medicine is billed separately, your real out-of-pocket depends entirely on your prescription drug coverage, not on PlushCare's fees. If your insurance covers a GLP-1, the visit can be inexpensive and the drug a manageable copay. If it doesn't, you're paying cash at a pharmacy for a brand-name injectable — which can run well over a thousand dollars a month at list price. For comparison, the category median for an all-inclusive compounded plan sits near $170, but that's not what PlushCare sells, so it isn't an apples-to-apples number.

It prescribes real brand-name GLP-1s — and nothing compounded

This is where PlushCare differs sharply from most of the telehealth field. Its physicians prescribe the actual FDA-approved branded drugs — Wegovy and Ozempic (semaglutide), Zepbound and Mounjaro (tirzepatide), and Saxenda. There is no in-house compounding pharmacy and no cheaper compounded vial here; PlushCare sends a prescription to a regular retail pharmacy, and you fill it like any other medication. For people who specifically want the brand-name product and plan to run it through insurance, that's a genuine advantage. For people hoping to dodge brand pricing with a low-cost compounded version, PlushCare simply doesn't offer that path.

  • You get: a video visit with a board-certified physician (MDs, not nurse practitioners only), in all 50 states, who can prescribe brand-name GLP-1s and manage the rest of your health too.
  • You don't get: any medication in the price, a compounded discount option, or a guarantee that a GLP-1 will be prescribed at your first visit.
  • You pay: a per-visit fee plus a monthly membership — separately from whatever your pharmacy charges for the drug.

The honest catch: prescribing isn't guaranteed, and there's an active billing lawsuit

Two drawbacks matter enough to slow you down. First, a GLP-1 is not promised. The physician decides at the appointment whether it's appropriate, so it's entirely possible to pay the visit fee, sign up for the membership, and walk away without the prescription you came for. Go in understanding the appointment is a real medical evaluation, not a checkout for a drug you've already chosen.

Second, and more serious: PlushCare is facing a California class-action lawsuit alleging deceptive subscription enrollment and unauthorized charges after customers tried to cancel. That isn't an isolated gripe — the Better Business Bureau complaint pattern centers on the same theme, the membership being hard to cancel and continuing to bill. We treat that as material. If you sign up, watch the recurring membership closely, keep records of any cancellation, and check your statements.

Who it's owned by, and what that means for trust

Unlike many telehealth brands with murky ownership, PlushCare has a clearly named corporate parent: it's a subsidiary of Transcarent, Inc., a Delaware company that also owns Accolade, 2nd.MD, and 98point6. A named, venture-backed parent and board-certified MDs are real trust signals, and there are no FDA warning letters on file for PlushCare. But we deliberately hold our confidence in PlushCare at a moderate level — not high — because of the open litigation and the consistent billing-complaint pattern. Good doctors and a solid corporate structure don't cancel out an unresolved class action over how customers are charged. You can read how we weigh these factors in our scoring methodology.

Who should choose PlushCare — and who should skip it

Choose PlushCare if you want an ongoing relationship with a real physician who can manage your whole health, you have prescription coverage you intend to use for a brand-name GLP-1, and you value seeing an MD over a one-purpose weight-loss funnel. Skip it if you're uninsured and want a predictable all-in monthly price, if you specifically want low-cost compounded semaglutide or tirzepatide, or if you want a guarantee that you'll leave your first visit with a GLP-1 prescription in hand.

Bottom line

PlushCare is a legitimate virtual primary-care practice with board-certified doctors who happen to be able to prescribe brand-name GLP-1s — not a dedicated weight-loss program, and not a source of cheap compounded medication. Its strengths are real physicians, nationwide access, and transparent ownership. Its weaknesses are a fee-plus-membership model that leaves the drug cost entirely on you and an active lawsuit over its billing practices. For an insured patient who wants a doctor first and a GLP-1 second, it's worth a look — with your eyes open about the membership and your bank statements.

For a side-by-side, Yucca Health ($146/month) and DudeMeds ($149/month) are the most comparable options to weigh against PlushCare.

Ready to start with PlushCare?

Starting at $149/month. See current pricing and start your free consultation.

Alternatives to PlushCare

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this PlushCare review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with PlushCare?

Starting at $149/month. See current pricing and start your free consultation.